Cardiovascular disease - DiabetesontheNet

Judicious use of ACE inhibitors: No time to waste?

Cardiovascular risk in people with metabolic syndrome and diabetes

Hyperglycaemia and coronary heart disease: The meta picture

Don’t throw the baby out with the bath water! The effect of the Quality and Outcomes Framework on UK diabetes care

A role for retinopathy in predicting cardiovascular disease

Cardiovascular disease, type 2 diabetes and the metabolic syndrome: Effects of fenofibrate treatment

Risk calculation: An important part of diabetes care

Implementing the NHS Health Checks programme

Cardiovascular disease risk estimation: Why, when and how?

Intensive glucose-lowering and cardiovascular disease

Controlling hyperglycaemia and cardiovascular benefit: The story continues

Influence of hyperglycaemia on stroke outcomes

Intensive glucose lowering in the VADT study did not increase risk of cardiovascular events in people with type 2 diabetes

Recognising chronic kidney disease as a risk equivalent for coronary heart disease

Will screening for diabetes reduce cardiovascular disease?

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Metabolic syndrome: Believe in it or not, the risk factors matter

Determining risk of myocardial infarction in men and women with type 2 diabetes in the UK